Webinar Series

Cerus offers educational webinars on topics of relevance to the field of pathogen inactivation. The webinars will feature key thought leaders in transfusion medicine and share specific real world examples of how the INTERCEPT Blood System has been successfully implemented into blood centers, resulting in more efficient inventory management and in safer blood components.

2010 Webinars

Language	Event	Broadcast
Language: English	RBC and Immune Response George Garratty, PhD, FRCPath American Red Cross Blood Services Southern California Region	View Webinar
Language: English	Active Hemovigilance Results for INTERCEPT - Review of Multi-Year Studies Presented at International Hemovigilance Seminar (IHS) William F. Reed, M.D. Cerus Corporation Concord, California, USA	View Webinar
Language: English	Current Status of RBC Component Viability Requirements Larry J. Dumont, PhD Dartmouth-Hitchocock Medical Center Lebanon, New Hampshire, USA Jose A. Cancelas-Perez, MD Hoxworth Blood Center Cincinnatti, Ohio, USA	View Webinar

2009 Webinar Replays

Language	Event	Broadcast date
Language: English	Clinical Trials in Transfusion Medicine Dr. Jeffrey McCullough University of Minnesota Minneapolis, Minnesota Ms. Nancy Heddle McMaster University & Canadian Blood Services Hamilton, ON, Canada	November 11, 2009 108 minutes Webinar Replay
Lengua: Español	La seguridad de la Sangre en España en la Era de la Inactivación de Patógenos--España como pionera en iniciativas de seguridad de la sangre Dr. Miguel Lozano Hospital Clinic Barcelona Barcelona, España Dra. Emma Castro Centro de Transfusión de Cruz Roja Española Madrid, España	4 de nov 2009 55 minutes Webinar Replay
Language: German	Vorteile von INTERCEPT Plasma im Vergleich zu Quarantäne Plasma (Operational Benefits of INTERCEPT Plasma versus Quarantine Plasma) Dr. med. Markus M. Müller DRK-Blutspendedienst, Baden-Wuerttemberg-Hessen Frankfurt am Main Dr. Johannes Irsch Cerus B.V. Amersfoort, Niederlan	Sep 22, 2009 56 minutes Webinar Replay
Language: English	Role of Pathogen Inactivation in Preparedness for Pandemic H1N1 and Emerging Pathogens Dr. Richard Benjamin American Red Cross Washington DC, USA Dr. Carl Hanson California Department of Public Health California, USA	Sep 9, 2009 58 minutes Webinar Replay
Language: English	The INTERCEPT Blood System in Routine Use: 3 and 5-Year Experiences Dr. Jean-Pierre Cazenave EFS-Alsace Strasbourg, France Dr. Jean-Claude Osselaer Cliniques Universitaires de Mont-Godinne, Universite Catholique de Louvain, Yvoir, Belgium	Oct 20, 2009 62 minutes Webinar Replay